China, Oct. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy, Associated Factors, and Safety of Intravesical Bacillus CalmetteGuérin in Patients with Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer: A Single-Center Ambidirectional Cohort Study'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600134511
Registration Time: 2026/10/15
Type: Observational study
Primary Sponsor: The First Affiliated Hospital of Wenzhou Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=347794
Published by HT Digital Content Services with permission from Health Daily Digest....